SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?

Eur Heart J. 2020 May 14;41(19):1801-1803. doi: 10.1093/eurheartj/ehaa235.

Gabriela M Kuster^{1

2}, Otmar Pfister^{1

2}, Thilo Burkard^{1

3}, Qian Zhou¹, Raphael Twerenbold^{1

4}, Philip Haaf¹, Andreas F Widmer⁵, Stefan Osswald¹

¹ Clinic of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
² Department of Biomedicine, University Hospital Basel and University of Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
³ Hypertension Clinic, Medical Outpatient Clinic, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.
⁴ Cardiovascular Research Institute Basel (CRIB), University Hospital Basel, Spitalstrasse 2, 4056 Basel, Switzerland.
⁵ Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.

No abstract available